Differential effects of the iodinated contrast agents Ioxaglate, Iohexol and Iodixanol on thrombus formation and fibrinolysis

Corot, 1989, Effect of iodinated contrast media on blood clotting, Invest. Radiol., 24, 390, 10.1097/00004424-198905000-00010 Kopko, 1990, Thrombin generation in non-clottable mixtures of blood and non-ionic contrast agents, Radiology, 174, 459, 10.1148/radiology.174.2.2296655 Corot, 1996, In vitro comparison of the effects of contrast media on coagulation and platelet activation, Blood Coagul. Fibrinolysis, 7, 602, 10.1097/00001721-199609000-00005 Al Dieri, 2000, Anticoagulant and antiplatelet effect of an ionic iodinated contrast medium, but not of a non-ionic one, Am. J. Cardiol., 86, 100i Idee, 1999, Thrombotic risk associated with the use of iodinated contrast media in interventional cardiology: pathophysiology and clinical aspects, Fundam. Clin. Pharmacol., 13, 613, 10.1111/j.1472-8206.1999.tb00372.x Jung, 2002, Effect of an ionic compared to a non-ionic X-ray contrast agent on platelets and coagulation during diagnostic cardiac catheterization, Pathophysiol. Haemost. Thromb., 32, 121, 10.1159/000065213 Levi, 1991, Variable effects of radiological contrast media on thrombus growth in a rabbit jugular vein thrombosis model, Thromb. Haemost., 66, 218, 10.1055/s-0038-1646393 Grines, 1991, Acute thrombosis in a canine model of arterial injury: effect of ionic versus non-ionic contrast media, J. Invas.Cardiol., 3, 18B Moncada, 1993, Comparative procoagulant actions of ionic and non-ionic contrast media as studied in a rat model of laser induced thrombosis, Thromb. Haemost., 69, 1027 Corot, 1994, Effect of iodinated contrast agents on the formation of platelet thrombi in the micro arterioles of rats, Invest. Radiol., 29, S203, 10.1097/00004424-199406001-00067 Labarthe, 2003, In vivo comparative antithrombotic effects of Ioxaglate and Iohexol and interaction with the platelet antiaggregant Clopidogrel, Invest. Radiol., 38, 34, 10.1097/00004424-200301000-00005 Robertson, 1987, Blood clot formation in angiographic syringes containing non-ionic contrast media, Radiology, 163, 621, 10.1148/radiology.162.3.3809474 Zhu, 2002, Do clinically relevant circulating concentrations of radiographic contrast agents inhibit platelet-dependent arterial thrombosis?, Thromb. Res., 105, 413, 10.1016/S0049-3848(02)00039-7 Corot, 1991, Scanning electron microscopic analysis of catheters during routine angiographic procedures. Role of the contrast agent, Invest. Radiol., 26, S96, 10.1097/00004424-199111001-00032 Markou, 2001, Antithrombotic effects of ionic and non-ionic contrast media in nonhuman primates, Thromb. Haemost., 85, 488, 10.1055/s-0037-1615610 Grabowski, 1993, Platelet adhesion/aggregation in an in vitro model of coronary artery stenosis, Catheter. Cardiovasc. Diagn., 28, 65, 10.1002/ccd.1810280113 Dalby, 2002, Systemic platelet effects of contrast media: implications for cardiologic research and clinical practice, Am. Heart J., 143, E1, 10.1067/mhj.2002.119998 Eloy, 1991, Contrast media for angiography: physicochemical properties, pharmacokinetics and biocompatibility, Clin. Mater., 7, 89, 10.1016/0267-6605(91)90045-H Chronos, 1993, Profound platelet degranulation is an important side effect of some types of contrast media used in interventional cardiology, Circulation, 88, 2035, 10.1161/01.CIR.88.5.2035 Grabowski, 1995, Variability of platelet degranulation by different contrast media, Acta Radiol., 3, S485 Heptinstall, 1998, Differential effects of three radiographic contrast media on platelet aggregation and degranulation: implications for clinical practice, Br. J. Haematol., 103, 1023, 10.1046/j.1365-2141.1998.01118.x Li, 1997, Differences between contrast media in the inhibition of platelet activation by specific platelet agonists, Acad. Radiol., 4, 108, 10.1016/S1076-6332(97)80009-8 Al Dieri, 2003, The ionic contrast medium Ioxaglate interferes with thrombin-mediated activation of factor V, factor VIII and platelets, J. Thromb. Haemost., 1, 269, 10.1046/j.1538-7836.2003.00026.x Gabriel, 1991, Platelet and fibrin modification by radiographic contrast media, Circ. Res., 68, 881, 10.1161/01.RES.68.3.881 Granger, 1992, Fibrin modification by ionic and non-ionic contrast media during cardiac catheterisation, Am. J. Cardiol., 69, 821, 10.1016/0002-9149(92)90517-3 Melton, 1998, Alterations in fibrin detected in coronary sinus blood after heparin and coronary angiography with a non-ionic contrast agent (Iohexol), Am. J. Cardiol., 82, 295, 10.1016/S0002-9149(98)00330-0 Farrehi, 2001, An analysis of mechanisms underlying the antifibrinolytic properties of radiographic contrast agents, J. Thromb. Thrombolysis, 12, 273, 10.1023/A:1015283210156 Carr, 1995, Effects of ionic and non-ionic contrast media on clot structure, platelet function and thrombolysis mediated by tissue plasminogen activator in plasma clots, Haemostasis, 25, 172 Dehmer, 1995, Impairment of fibrinolysis by streptokinase, urokinase and recombinant tissue-type plasminogen activator in the presence of radiographic contrast agents, JACC, 25, 1069, 10.1016/0735-1097(94)00528-X Chandler, 1958, In vitro thrombotic coagulation of blood, Lab. Invest., 7, 110 Robbie, 1997, Thrombi formed in the Chandler loop mimic human arterial thrombi in structure and PAI-1 content and distribution, Thromb. Haemost., 77, 510, 10.1055/s-0038-1655998 Sutton, 2002, A randomized prospective trial of Ioxaglate 320 (Hexabrix) vs. Iodixanol 320 (Visipaque) in patients undergoing percutaneous coronary intervention, Catheter. Cardiovasc. Interv., 57, 346, 10.1002/ccd.10326